282 related articles for article (PubMed ID: 29592538)
1. Enoxaparin Dosing at Extremes of Weight: Literature Review and Dosing Recommendations.
Sebaaly J; Covert K
Ann Pharmacother; 2018 Sep; 52(9):898-909. PubMed ID: 29592538
[TBL] [Abstract][Full Text] [Related]
2. Increased Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in General Trauma Patients.
Walker CK; Sandmann EA; Horyna TJ; Gales MA
Ann Pharmacother; 2017 Apr; 51(4):323-331. PubMed ID: 28228055
[TBL] [Abstract][Full Text] [Related]
3. Dosing of enoxaparin for venous thromboembolism prophylaxis in obese patients.
Willett KC; Alsharhan M; Durand C; Cooper MR
Ann Pharmacother; 2013 Dec; 47(12):1717-20. PubMed ID: 24301685
[TBL] [Abstract][Full Text] [Related]
4. Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients.
Ludwig KP; Simons HJ; Mone M; Barton RG; Kimball EJ
Ann Pharmacother; 2011 Nov; 45(11):1356-62. PubMed ID: 22009998
[TBL] [Abstract][Full Text] [Related]
5. Enoxaparin Thromboprophylaxis Dosing and Anti-Factor Xa Levels in Low-Weight Patients.
Yam L; Bahjri K; Geslani V; Cotton A; Hong L
Pharmacotherapy; 2019 Jul; 39(7):749-755. PubMed ID: 31112313
[TBL] [Abstract][Full Text] [Related]
6. Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients.
Rondina MT; Wheeler M; Rodgers GM; Draper L; Pendleton RC
Thromb Res; 2010 Mar; 125(3):220-3. PubMed ID: 19272635
[TBL] [Abstract][Full Text] [Related]
7. Thrombelastography-Based Dosing of Enoxaparin for Thromboprophylaxis in Trauma and Surgical Patients: A Randomized Clinical Trial.
Connelly CR; Van PY; Hart KD; Louis SG; Fair KA; Erickson AS; Rick EA; Simeon EC; Bulger EM; Arbabi S; Holcomb JB; Moore LJ; Schreiber MA
JAMA Surg; 2016 Oct; 151(10):e162069. PubMed ID: 27487253
[TBL] [Abstract][Full Text] [Related]
8. Enoxaparin dosing after cesarean delivery in morbidly obese women.
Overcash RT; Somers AT; LaCoursiere DY
Obstet Gynecol; 2015 Jun; 125(6):1371-1376. PubMed ID: 26000508
[TBL] [Abstract][Full Text] [Related]
9. A Weight- and Anti-Xa-Guided Enoxaparin Dosing Protocol for venous thromboembolism Prophylaxis in intensive care unit Trauma Patients.
Bigos R; Solomon E; Dorfman JD; Ha M
J Surg Res; 2021 Sep; 265():122-130. PubMed ID: 33930618
[TBL] [Abstract][Full Text] [Related]
10. Prospective Evaluation of Weight-Based Prophylactic Enoxaparin Dosing in Critically Ill Trauma Patients: Adequacy of AntiXa Levels Is Improved.
Nunez JM; Becher RD; Rebo GJ; Farrah JP; Borgerding EM; Stirparo JJ; Lauer C; Kilgo P; Miller PR
Am Surg; 2015 Jun; 81(6):605-9. PubMed ID: 26031274
[TBL] [Abstract][Full Text] [Related]
11. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.
Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG
JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333
[TBL] [Abstract][Full Text] [Related]
12. Increased enoxaparin dosing is required for obese children.
Lewis TV; Johnson PN; Nebbia AM; Dunlap M
Pediatrics; 2011 Mar; 127(3):e787-90. PubMed ID: 21321026
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of thromboprophylaxis with enoxaparin for prevention of pregnancy-associated venous thromboembolism.
Cox S; Eslick R; McLintock C
J Thromb Haemost; 2019 Jul; 17(7):1160-1170. PubMed ID: 31013386
[TBL] [Abstract][Full Text] [Related]
14. Weight-based enoxaparin dosing for venous thromboembolism prophylaxis in the obese trauma patient.
Bickford A; Majercik S; Bledsoe J; Smith K; Johnston R; Dickerson J; White T
Am J Surg; 2013 Dec; 206(6):847-51, discussion 851-2. PubMed ID: 24070664
[TBL] [Abstract][Full Text] [Related]
15. Achievement of goal anti-Xa activity with weight-based enoxaparin dosing for venous thromboembolism prophylaxis in trauma patients.
Taylor A; Huang E; Waller J; White C; Martinez-Quinones P; Robinson T
Pharmacotherapy; 2021 Jun; 41(6):508-514. PubMed ID: 33864688
[TBL] [Abstract][Full Text] [Related]
16. Review of current evidence available for guiding optimal Enoxaparin prophylactic dosing strategies in obese patients-Actual Weight-based vs Fixed.
He Z; Morrissey H; Ball P
Crit Rev Oncol Hematol; 2017 May; 113():191-194. PubMed ID: 28427508
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an enoxaparin dosing calculator using burn size and weight.
Faraklas I; Ghanem M; Brown A; Cochran A
J Burn Care Res; 2013; 34(6):621-7. PubMed ID: 24043245
[TBL] [Abstract][Full Text] [Related]
18. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.
Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ
JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732
[TBL] [Abstract][Full Text] [Related]
19. A case series of LMWH use in pregnancy: should trough anti-Xa levels guide dosing?
Berresheim M; Wilkie J; Nerenberg KA; Ibrahim Q; Bungard TJ
Thromb Res; 2014 Dec; 134(6):1234-40. PubMed ID: 25450535
[TBL] [Abstract][Full Text] [Related]
20. Chemical prophylaxis to prevent venous thromboembolism in morbid obesity: literature review and dosing recommendations.
Vandiver JW; Ritz LI; Lalama JT
J Thromb Thrombolysis; 2016 Apr; 41(3):475-81. PubMed ID: 25982217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]